This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2010 Oct;85(10):782-6.

doi: 10.1002/ajh.21806.

Iron chelation therapy for patients with sickle cell disease and iron overload

Adlette Inati¹, Evelyne Khoriaty, Khaled M Musallam, Ali T Taher

Affiliations

Affiliation

¹ Division of Pediatric Hematology and Oncology, Children's Centre for Cancer and Blood Diseases, Rafik Hariri University Hospital, Beirut, Lebanon. adlette.inati@lau.edu.lb

PMID: 20721892
DOI: 10.1002/ajh.21806

Free article

Case Reports

Iron chelation therapy for patients with sickle cell disease and iron overload

Adlette Inati et al. Am J Hematol. 2010 Oct.

Free article

. 2010 Oct;85(10):782-6.

doi: 10.1002/ajh.21806.

Authors

Adlette Inati¹, Evelyne Khoriaty, Khaled M Musallam, Ali T Taher

Affiliation

¹ Division of Pediatric Hematology and Oncology, Children's Centre for Cancer and Blood Diseases, Rafik Hariri University Hospital, Beirut, Lebanon. adlette.inati@lau.edu.lb

PMID: 20721892
DOI: 10.1002/ajh.21806

No abstract available

PubMed Disclaimer

Similar articles

Daily alternating deferasirox and deferiprone therapy for "hard-to-chelate" beta-thalassemia major patients.
Balocco M, Carrara P, Pinto V, Forni GL. Balocco M, et al. Am J Hematol. 2010 Jun;85(6):460-1. doi: 10.1002/ajh.21711. Am J Hematol. 2010. PMID: 20513129 No abstract available.
Iron-chelating therapy for transfusional iron overload.
Brittenham GM. Brittenham GM. N Engl J Med. 2011 Jan 13;364(2):146-56. doi: 10.1056/NEJMct1004810. N Engl J Med. 2011. PMID: 21226580 Free PMC article. Review.
[Pathogenesis of transfusional iron overload and iron chelation therapy].
Ozawa K. Ozawa K. Rinsho Ketsueki. 2009 Jul;50(7):527-31. Rinsho Ketsueki. 2009. PMID: 19638719 Review. Japanese. No abstract available.
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease.
Vichinsky E, Onyekwere O, Porter J, Swerdlow P, Eckman J, Lane P, Files B, Hassell K, Kelly P, Wilson F, Bernaudin F, Forni GL, Okpala I, Ressayre-Djaffer C, Alberti D, Holland J, Marks P, Fung E, Fischer R, Mueller BU, Coates T; Deferasirox in Sickle Cell Investigators. Vichinsky E, et al. Br J Haematol. 2007 Feb;136(3):501-8. doi: 10.1111/j.1365-2141.2006.06455.x. Br J Haematol. 2007. PMID: 17233848 Free PMC article. Clinical Trial.
Efficacy and safety of deferasirox compared with deferoxamine in sickle cell disease: two-year results including pharmacokinetics and concomitant hydroxyurea.
Vichinsky E, Torres M, Minniti CP, Barrette S, Habr D, Zhang Y, Files B; study CICL670A2201 investigators. Vichinsky E, et al. Am J Hematol. 2013 Dec;88(12):1068-73. doi: 10.1002/ajh.23569. Epub 2013 Sep 19. Am J Hematol. 2013. PMID: 23946212 Clinical Trial.

See all similar articles

Cited by

Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents.
Pretorius E, Bester J, Vermeulen N, Lipinski B, Gericke GS, Kell DB. Pretorius E, et al. PLoS One. 2014 Jan 9;9(1):e85271. doi: 10.1371/journal.pone.0085271. eCollection 2014. PLoS One. 2014. PMID: 24416376 Free PMC article.
Chelation therapy for iron overload: nursing practice implications.
Eckes EJ. Eckes EJ. J Infus Nurs. 2011 Nov-Dec;34(6):374-80. doi: 10.1097/NAN.0b013e3182306356. J Infus Nurs. 2011. PMID: 22101631 Free PMC article. Review.
Iron Chelation with Transdermal Deferoxamine Accelerates Healing of Murine Sickle Cell Ulcers.
Rodrigues M, Bonham CA, Minniti CP, Gupta K, Longaker MT, Gurtner GC. Rodrigues M, et al. Adv Wound Care (New Rochelle). 2018 Oct 1;7(10):323-332. doi: 10.1089/wound.2018.0789. Epub 2018 Oct 11. Adv Wound Care (New Rochelle). 2018. PMID: 30374417 Free PMC article.
Sickle cell disease in children.
Meier ER, Miller JL. Meier ER, et al. Drugs. 2012 May 7;72(7):895-906. doi: 10.2165/11632890-000000000-00000. Drugs. 2012. PMID: 22519940 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information